Search: 2018 EU Meeting Faculty
Results 1 - 6 of 6

Rachel Jones

Patient Engagement Consultant
admedicum Business for Patients GmbH & Co KG

Bio: Rachel Jones started her career as a Community Pharmacist in the UK Healthcare system and she quickly realised that her role was most valuable when she equipped people with the information and tools to understand their own health and the medicines that were needed as part of their care. In her most recent role within AstraZeneca, Rachel has been charged with inputting the patient centric strategy as a Global, companywide initiative. One of her key land mark projects has been to facilitate a consumer charter for the company which was led by patients and their families to add insight and direction to the way in which a large corporate body conducts its business. She is also mid way through her masters in Behavioural Change and is the senior author on a peer reviewed manuscript which was published in the BMJ in 2016 in relation to patient centricity.

Sajan Khosla

Head of Real World Evidence ¿ Centre of Excellence

Bio: Sajan Khosla is the Head, Real World Evidence Centre of Excellence (RWE CoE). In this capacity Sajan leads a global team accountable for; execution of the RWE strategy, including maximizing data assets through innovative analytics, key collaborations with RWE research partners, delivery of RWE studies, and driving AZ's medical evidence capability globally as well as in partnership with local countries. Sajan has been with AZ for over 10 years, working his way through the pipeline from early discovery research, following his passion for clinical research in the phase II to phase III trial design to his current role in Global Medical Affairs. Sajan lead teams within AstraZeneca to deliver innovations in generating evidence for Global Medical Affairs and he has been a key driver of the cross fertilisation of Real World Evidence for clinical development. While in clinical development Sajan also led a strategic initiative to develop Pragmatic Clinical Trials (PCTs) for indication seeking studies which has delivered guidance to clinical teams on PCTs and more recently worked with product teams to develop a pilot PCT study to be reviewed by US and EU regulators. Sajan has also found time to disperse his AZ career with time outside the industry in the National Health Service where he established the first Clinical Informatics team within the NHS. Here Sajan worked alongside the Medical Director for University Hospitals Birmingham to design and deliver a new analytics platform used to monitor and predict patient safety observations. Additionally, Sajan worked in a Silicon Valley data science start-up where he developed a Health Data Science unit which enabled many top 10 pharma companies deliver a data science strategy using machine learning and artificial intelligence.

Robert Kiley

Head of Open Research
Wellcome Trust

Bio: Robert Kiley is Head of Open Research at the Wellcome Trust where he is responsible for developing and implementing an open research strategy. The overarching aim is to help ensure that researchers are equipped, empowered and motivated to make research outputs findable, accessible and usable and to use these outputs to accelerate research and improve health. Over the past decade Robert has played a leading role in the implementation of Wellcome's open access policy and overseeing the development of the Europe PubMed Central repository. Robert also acts as the point of contact for eLife, the open-access research journal, launched in 2012 with the support of the Howard Hughes Medical Institute, the Max Planck Society and the Wellcome Trust, and more recently championed the work to create a new open publishing platform for Wellcome researchers - Wellcome Open Research. Robert is a qualified librarian and an Associate Member of CILIP. Robert also sits as a Director on the ORCID Board.

Elizabeth Knowles

Associate Editorial Director, Medicine & Health
Taylor & Francis Group

Type of Company:
Professional Degrees: BA/BS

Bio: Liz is Associate Editorial Director for the Medicine & Health journals at Taylor & Francis and has worked on medical journals for the last 10 years. She currently works on the rapid publication journals CMRO and Postgraduate Medicine as well as with the in house Expert Collection commissioning team. In addition, Liz has recently begun working on the Dove Medical Press journals that were recently acquired by Taylor & Francis. Her role is to find the most relevant journal for content being submitted to Taylor & Francis by medical communication and pharmaceutical companies, as well as academics.

Paul Lane

Associate Director Medical Communications
Biomarin Pharmaceutical Inc

Type of Company:
Professional Degrees: BA/BS, CMPP, PhD
CMPP Certified: (3/2010)

Bio: Paul conducted his Doctoral research into the physiological roles of nitric oxide at Weill Medical College of Cornell University. After serving on the faculty at Weill, Paul worked as a freelance consultant specializing in start-up grants for biotechnology companies, before transitioning full-time to medical publications. He has been a publications professional for over 10 years and has worked on programs spanning all stages of drug development in a variety of therapeutic areas. Until recently, Paul was responsible for Digital and Social Media strategy at Envision Pharma Group, but has now moved on to run publication programs for various rare diseases at Biomarin. The shift from print to web-based publications has been an area of interest since Paul authored a review in one of the first online journals (Science:STKE) in 2001. Much has changed since then, with journals and congresses now offering a plethora of enhancements and the rise of social media as a channel for information dissemination. These additions not only change the way in which medical information is consumed, but also the methods we use to assess the impact of a publication.

Rebecca Lawrence

Managing Director

Bio: Rebecca Lawrence is Managing Director of F1000, providers of a series of tools and services to support the research community in writing, publishing, discovering and evaluating new scientific findings. She was responsible for the launch of the novel open science publishing platform F1000Research. She has subsequently led the initiative behind the recent launch of Wellcome Open Research, Gates Open Research, and many other funder- and institution-based publishing platforms that aim to start a new trajectory in the way scientific findings and data are communicated and ultimately research and researchers are evaluated. She is a member of the High-Level Advisory Group for the EU's Open Science Policy Platform, and has been co-Chair of a number working groups focussing on data and peer review, for organisations including the Research Data Alliance (RDA), CASRAI and ORCID. She has worked in STM publishing for 15 years, originally trained and qualified as a pharmacist, and holds a PhD in Cardiovascular Pharmacology.